Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis.
about
Urinary tract infections: epidemiology, mechanisms of infection and treatment optionsGlobal functional analyses of cellular responses to pore-forming toxinsContribution of Escherichia coli alpha-hemolysin to bacterial virulence and to intraperitoneal alterations in peritonitis.In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variantsMucosal immunization with iron receptor antigens protects against urinary tract infection.Inactivation of Pasteurella (Mannheimia) haemolytica leukotoxin causes partial attenuation of virulence in a calf challenge model.Waging war against uropathogenic Escherichia coli: winning back the urinary tractCytotoxicity of hemolytic, cytotoxic necrotizing factor 1-positive and -negative Escherichia coli to human T24 bladder cells.Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coliPhylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection.A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice.Genetic conservation of hlyA determinants and serological conservation of HlyA: basis for developing a broadly cross-reactive subunit Escherichia coli alpha-hemolysin vaccine.Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.Identification of urovirulence traits in Escherichia coli by comparison of urinary and rectal E. coli isolates from dogs with urinary tract infectionThe Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infectionAntibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence of an extraintestinal isolate of Escherichia coliIn vivo gene expression analysis identifies genes required for enhanced colonization of the mouse urinary tract by uropathogenic Escherichia coli strain CFT073 dsdA.The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways.Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coliA killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection.Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins.A biomimetic nanosponge that absorbs pore-forming toxinsDrug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.P2X receptor-dependent erythrocyte damage by α-hemolysin from Escherichia coli triggers phagocytosis by THP-1 cells.Uropathogenic Escherichia coli-Associated ExotoxinsProtective effect of mitochondria-targeted antioxidants in an acute bacterial infectionInsulin and the phosphatidylinositol 3-kinase signaling pathway regulate Ribonuclease 7 expression in the human urinary tract.Two pathogenicity islands in uropathogenic Escherichia coli J96: cosmid cloning and sample sequencing.A Novel Biomimetic Nanosponge Protects the Retina from the Enterococcus faecalis Cytolysin.
P2860
Q27022487-55F76773-665A-40AD-BE35-C18B9B69AA5BQ27312103-32AD43A4-6529-4048-B0E4-1426D7E14AA3Q30304556-9C49926F-5FD2-4F73-BC20-E06610DAB80BQ30452859-69608BFA-9012-4B73-8035-19BAB7D564BAQ33508792-3372AC2A-C26B-4FC0-A5DB-144B08826645Q33596232-CA02E06A-0B6F-4B80-AA08-EA1ADF8BE6C5Q33613902-CC3EC6EC-81A4-4944-A9F3-4013B9A01A1BQ33756728-AB4B86B2-726F-4698-AF1F-5586DBEB8BF5Q33927393-DB04E591-5424-4BA9-8A92-C8ED232596ADQ34041647-9ED0A92D-4CE7-4CD3-8E24-23BDDFC09E9DQ34045099-255A5F77-4AA2-481F-8A41-0F19A3779E0CQ34527547-A74E5014-0BF1-41F1-914D-DB0A6B372E3DQ34641267-9410FFFD-D91A-4DA0-B2BD-A10367336F46Q34748777-297E7847-3B80-4FBD-8688-797B629A34F3Q34943892-9080714C-679F-4CED-AA80-A9A7980796ACQ35134655-B7D17386-F3EE-4808-9691-C3DE17BF5AD3Q35187543-CB6905D7-0FA2-48B6-BF16-44CCD853B1EAQ35501002-6F68569A-2F3B-4B00-9322-23F887777B6FQ35689047-396CDA2E-2D07-424E-9644-C05D5DFA4395Q35697535-501A56BF-5AFA-4C53-9BF6-0572F7169A89Q35783832-250A4387-A9A0-450A-B5E7-986D1AF374E9Q35878788-A9C445B5-04E9-4257-934B-234714DE4E3FQ35949664-062405E8-BB87-413F-B65E-6C6277EC6DD4Q36536668-A90E5DDD-568A-4DC2-812D-69EBB3417FADQ36828355-CBFFFDC1-E42B-43EA-9B26-372285DB754CQ36951570-B1B89B98-76FA-4BB7-B765-E30EA7F46FACQ36993864-DB41A30C-6D6F-471D-B9A0-0D10B7FAB469Q37035981-73365F02-4AC0-4B84-9610-EB21F7D5082CQ37103854-409DDE3E-AC0A-4FBF-B704-76FDAF2879AEQ39612821-48757763-B43E-4637-BAAB-6E34034DBBBAQ39825974-38AFB263-95EF-46D1-B849-06247EFA548EQ46189476-ED01C82F-42D5-4956-A9FF-AF9D4E11AE39
P2860
Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Alpha-hemolysin contributes to ...... mouse model of pyelonephritis.
@en
type
label
Alpha-hemolysin contributes to ...... mouse model of pyelonephritis.
@en
prefLabel
Alpha-hemolysin contributes to ...... mouse model of pyelonephritis.
@en
P2093
P2860
P1476
Alpha-hemolysin contributes to ...... mouse model of pyelonephritis.
@en
P2093
P2860
P304
P407
P577
1991-03-01T00:00:00Z